The protooncogene c-src encodes a tightly regulated non-receptor tyrosine kinase. c-Src plays a key role in cell adhesion, cell morphology and motility as well as in cell proliferation and survival. Elevated c-Src protein expression level and increased kinase activity have been found in several human cancers. Deletion of the C-terminal sequence results in a constitutively activated c-Src mutant detected in some human colon carcinoma. Replacement of the C-terminal sequence is characteristic for v-Src, the viral homologue of c-Src encoded by the avian Rous Sarcoma Virus (RSV), which causes tumours in chickens. In this study we describe the very C-terminus of c-Src as ligand for a PDZ domain protein. PDZ domain proteins are multidomain proteins and function as scaffolds to organize cell adhesion complexes, to cluster transmembrane proteins, and to align proteins of a signalling cascade, e.g. shown for Src/Raf-1 signalling. In many cases PDZ proteins mediate anti-proliferative effects. Here, we demonstrate by mutational analysis that the C-terminal amino acid Leu of c-Src is essential for the binding to a PDZ domain. As candidate PDZ protein we identified AF-6, a junctional adhesion protein, involved in formation and maintenance of cell junctions and in negative regulation of signalling. We show that the PDZ domain of AF-6 strongly restricts the number of c-Src substrates, while knock-down of AF-6 has the opposite effect. The AF-6 PDZ domain interferes with phosphorylation of c-Src at Tyr 527 by the C-terminal Src kinase, CSK, and reduces autophosphorylation at Tyr 416 resulting in a moderately activated c-Src protein. The interaction of c-Src with a PDZ domain protein, e.g. AF-6, may spatially restrict c-Src to subcellular regions, e.g. cell-cell contacts. We identified a new type of negative regulation of c-Src through binding to a PDZ domain protein.

